Bioo Scientific Awarded $100K from NSF to Advance miRNA Rx Research with Mirna

The drug being developed is a mimic of miR-34, which plays a key role in the p53 tumor-suppressor pathway.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.